Clinical Trial Update: Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating whether low-dose aspirin protects renal function in patients with early diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Low-dose aspirin (acetylsalicylic acid)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Diabetic Nephropathy Type 2 | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING